CCMD
MDT icon

Cypress Capital Management (Delaware)’s Medtronic MDT Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,480
Closed -$675K – 116
2016
Q4 		$675K Buy
+9,480
New +$745K 0.18% 59

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Cypress Capital Management (Delaware)'s MDT Position: Q1 2017 in Review

Cypress Capital Management (Delaware) sold out of Medtronic (MDT) in Q1 2017, closing a stake of 9,480 shares — an estimated $675K sold.

Cypress Capital Management (Delaware) first reported a position in MDT in Q4 2016 and held it in 1 quarter. The position peaked at $675K in Q4 2016. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

  • Cypress Capital Management (Delaware) reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 9,480 Medtronic shares in Q1 2017, an estimated $675K.
  • Cypress Capital Management (Delaware) first reported a position in Medtronic in Q4 2016 and held it in 1 quarter.
  • Cypress Capital Management (Delaware)'s Medtronic position peaked at $675K in Q4 2016.
  • 1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q1 2017, filed 2 May 2017.